Skip to main content
SpringerLink
Log in

NICE issues osteoporosis prevention guidance

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Procter & Gamble Pharmaceuticals.National Institute for Health and Clinical Excellence (NICE) Final Appraisal Determination Recommends Treatment Options for Primary and Secondary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women. Media Release: 8 Jul 2008. Available from: URL: http://www.pgpharma.com

  2. NICE fails to act on risk of fracture, says osteoporosis charity. Internet Document: [1 page], 8 Jul 2008. Available from: URL: http://www.nos.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE issues osteoporosis prevention guidance. Pharmacoecon. Outcomes News 558, 3 (2008). https://doi.org/10.2165/00151234-200805580-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805580-00007

Keywords

Search

Navigation